Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylprednisolone for Prevention of OHSS in IVF
NCT01014104Phase 2Completed
- Sponsor
- Royan Institute
- Start
- Oct 2009
- Primary completion
- Aug 2010
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of methylprednisolone in ovarian hyperstimulation syndrome (OHSS), sponsored by Royan Institute. Started Oct 2009; status: completed.
02
Drugs
methylprednisolone
03
Conditions
ovarian hyperstimulation syndrome (OHSS)
Beyond the preview
Go deeper on NCT01014104.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01014104.